Lombard Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2015. For the quarter, the company reported revenue of $2.943 million compared to $4.758 million a year ago. Operating loss was $11.920 million compared to $8.934 million a year ago. Loss before taxation was $12.169 million compared to $8.9 million a year ago. Loss was $11.605 million compared to $8.283 million a year ago. Basic and diluted loss per ordinary share from continuing operations were of 58.4 cents compared to 51.2 cents a year ago.

For the year, the company reported revenue of $15.114 million compared to $13.277 million a year ago. Operating loss was $39.293 million compared to $36.143 million a year ago. Loss before taxation was $40.019 million compared to $35.979 million a year ago. Loss was $37.804 million compared to $34.752 million a year ago. Basic and diluted loss per ordinary share from continuing operations were of 212.9 cents compared to 238.7 cents a year ago. Net cash outflow from operating activities were of $33.796 million compared to $34.373 million a year ago. Purchase of property, plant and equipment were of $1.239 million compared to $1.481 million a year ago. Purchase of intangible assets was of $0.015 million compared to $0.266 million a year ago.

The Company expects to achieve year-over-year revenue growth in 2016 of approximately 20%.